Biology 207 Biology of Cancer

Lecture 17 "Brain Cancers"Spring 2004

Reading: Lemonick, “The tumor war”TIME 150, 46-53

Web sites: American Brain Tumor Association:

Oncolink:

Lecture Outline

1. Statistics and Risk factors

2. Classification

3. Astrocytomas

4. Diagnosis

5. Treatment/Blood-Brain Barrier

Lecture:

1. A. Statistics:

  • In 1997, 18,000 new brain tumors diagnosed; 50% increase from 10 years ago
  • Account for only 1.4% of cancers in U.S.
  • Not a major cancer, however most deadly because they interfere with essential life functions
  • Do not metastasize to other parts of the body

B. Risk factors

  • Radiation exposure
  • Impaired immune systems, HIV, other cancers
  • Heredity
  • Head trauma NOT a risk factor

2. Classification

Primary brain tumors: those that start in the brain

Secondary brain tumors: due to metastasis of other cancers to the brain

  • Primary tumors are classed based on cell type of origin

Most common brain tumors:

  • Astrocytomas=gliomas
  • Arise from astrocytes, which are glial cells
  • These make up the blood-brain barrier and contribute to nutrition of the central nervous system
  • Glial cells do divide in adults; nerve cells do not divide in adult
  • Cancers of nerve cells only occur in children and are called Neuroblastomas

Secondary brain tumors:

  • Most commonly spread from breast and lung
  • Colon cancers and melanomas can also spread to the brain
  • Cells of secondary tumor resemble the cells of the organ where the tumor started, not brain cells

3. Astrocytomas

World Health Organization tumor grading system

Tumor grades 1 4

1= slowest growing

4= fastest growing

Grade 1

  • Astrocytic tumor cells usually normal looking
  • Observe cell proliferation
  • Produce epileptic seizures as their only symptom
  • Can become quite large and increased pressure inside skull can lead to headaches, paralysis, personality change, coma and death
  • Prognosis good
  • Radiation therapy not recommended

Grade 2

  • Tumor cells slightly abnormal in appearance as well as number
  • No mitotic (dividing) cells usually observed
  • No necrosis (dead tissue)
  • Usually biopsied, not removed
  • Radiation treatment usually recommended to shrink tumor

Grade 3

  • "Malignant astrocytomas"--Can spread to other regions of brain or spine but not to other parts of the body
  • Observe "contrast enhancement" on CT and MRI scans
  • Cells are abnormal in appearance
  • Show evidence of mitosis
  • Cells in the tumor invade brain tissue
  • Confirm diagnosis with surgery or stereotactic biopsy
  • Follow up with radiation or chemotherapy
  • Average survival 18 months without treatment

Grade 4

  • Called glioblastomas
  • Most malignant form
  • Made of cells that infiltrate brain tissue
  • Mitotic cells frequently observed
  • Regions of dead tissue seen especially where growth of tumor has outpaced blood supply
  • Tumors induce angiogenesis, however new blood vessels may be abnormal
  • Obvious mass seen on CT and MRI scans
  • Very poor prognosis: survival 17 weeks with no treatment, about 1 year with certain treatments
  • Prognosis depends on age and performance status

4. Diagnosis of brain tumors:

Signs and symptoms of brain tumors:

  • Depend on location in brain
  • Size of tumor

May include:

  • Paralysis/numbness
  • Mood swings
  • Seizures
  • Loss of balance
  • Impaired vision

Generally a tumor on one side causes symptoms and impairment on opposite side; exception is cerebellum

Tumor may place pressure on the brain or cause build-up of fluid, leading to headaches. Headaches are most common presenting symptom

Neurological exam: Office visit to specialist doctor (Neurologist) to assess reflexes and brain function.

Scans: CT and MRI

  • Inject a dye to make abnormal tissue more obvious
  • Dyes concentrate more in disease tissues due to leakiness of blood vessels in and around brain tumors
  • CT better for tumors showing calcification (calcium deposits due to erosion of bone)
  • MRI better for small tumors, tumors next to bone, brain stem tumors
  • Low grade and metastatic tumors

CT scan=Computerized tomography

  • X-ray device combined with a computer
  • Patient lays on a table that slides into an opening like a doughnut hole in the scanner
  • X-rays penetrate brain from many directions, thousands of thin cross sections are fed into a computer that constructs a picture

MRI scan=Magnetic resonance imaging

  • Tunnel shaped piece of equipment
  • Magnetic field surrounds the head
  • Radio frequency pulse introduced; does not involve X-rays
  • Magnetic field causes atoms in brain to change direction
  • Radio frequency pulse causes another change in direction
  • Pulse stops; during relaxation, atoms give off energy in different amounts and at different intervals
  • Antennas pick up signals and feed them into a computer that assembles an image

Follow-up may involve biopsy

  • Surgery to remove tumor
  • Stereotactic biopsy=remove small piece of tissue with thin needle

5. Treatment options

Survival depends on

  • Type of tumor
  • Location of tumor

Therapy for Astrocytomas:

  • Generally not curable
  • Surgery often done after MRI or CT scan
  • Radiation: External beam or internal implants
  • Chemotherapy: Options still in clinical trials
  • Experimental therapies: immunotherapies, gene therapies

Problems with chemotherapies and other experimental therapies:

Blood--brain barrier--Blood vessels in the brain are not leaky because of connections between endothelial cells lining the blood vessels.

  • Most drugs can't diffuse from blood to get to tumor.
  • New drugs make blood vessels leaky so they can take up drugs

Example: Bradykinin analog RMP-7.

  • Bradykinin is naturally occurring body peptide with hormone action.
  • Analog can make blood-brain barrier leaky as site of tumors but not in normal regions of brain.
  • Combine RMP-7 with chemotherapeutic drug to deliver to brain tumor

Other strategies involve delivery of drugs with liposomes (lipid coat around drug molecules); fats (lipids) can cross the blood-brain barrier

Other approaches try to recruit patient's own immune system to attack brain cancer="immunotherapy"

1